
|Articles|February 15, 2004
FDA multicenter trial confirms CK safety, efficacy for hyperopia
Anaheim, CA-Conductive keratoplasty (CK), a thermokeratoplasty technique used to reshape the cornea, appears to be a safe and effective approach for treating low to moderate hyperopia with little or no induced astigmatism, according to Marguerite B. McDonald, MD, medical monitor of the FDA multicenter trial.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: The evolution of eye care on display at AAO 2025
2
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
3
AAO 2025: Clinical outcomes of early vs delayed pegcetacoplan treatment in GA
4
Ocular pickleball injuries rise sharply with increasing game popularity
5